7 completed. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
| Phase 2 | 1 | Completed 1 |
Follow Impetigo: new trials by email Literature Review of Impetigo trials Research Report on Impetigo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo Ozenoxacin, Placebo - Impetigo | Phase 3 | Completed | Ferrer Internacional S.A. | 412 | 2014-06-01 | 2024-08-20 |
| Safety and Efficacy of Mupirocin Gel in Children With Impetigo Mupirocin gel, Mupirocin ointment, Placebo - Impetigo | Phase 3 | Completed | Reig Jofre Group | 467 | 2014-02-01 | 2021-03-12 |
| Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo Experimental: CD07223 1.5 % Topical Gel BID, Experimental: CD07223 1.5% Topical Gel TID, Placebo Comparator: CD07223 vehicle gel BID - Impetigo | Phase 2 / Phase 3 | Completed | NovaBay Pharmaceuticals, Inc. | 328 | 2012-08-01 | 2014-08-12 |
| Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo ozenoxacin placebo, retapamulin 1% ointment, ozenoxacin 1% cream - Impetigo | Phase 3 | Completed | Ferrer Internacional S.A. | 465 | 2012-03-01 | 2016-07-01 |
| Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA Retpamulin Ointment, 1%, Linezolid - Skin Infections, Bacterial | Phase 3 | Completed | Stiefel, a GSK Company | 410 | 2009-04-01 | 2017-03-27 |
| Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo SB-275833 ointment, 1% - Skin Infections, Bacterial | Phase 3 | Completed | GlaxoSmithKline | 520 | 2005-04-01 | 2017-01-23 |
| Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment SB-275833 ointment, 1% - Impetigo | Phase 3 | Completed | GlaxoSmithKline | 210 | 2005-04-01 | 2016-09-23 |
Cellulitis (2)
Bacterial Infections (7) · Bacterial Infections and Mycoses (7) · Gram-Positive Bacterial Infections (7) · Infections (7) · Skin Diseases (7) · Skin Diseases, Bacterial (7) · Skin Diseases, Infectious (7) · Skin and Connective Tissue Diseases (7) · Staphylococcal Infections (7) · Staphylococcal Skin Infections (7) · Streptococcal Infections (7) · Connective Tissue Diseases (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
ozenoxacin (2) · Linezolid (1) · Mupirocin (1) · Ointments (1) · retapamulin (1)
Ferrer Internacional S.A. (2) · GlaxoSmithKline (2) · NovaBay Pharmaceuticals, Inc. (1) · Reig Jofre Group (1) · Stiefel, a GSK Company (1)
South Africa (3) · Germany (2) · India (2) · Mexico (2) · Netherlands (2) · Peru (2) · United States (2) · Canada (1) · Costa Rica (1) · France (1) · Italy (1) · Poland (1) · Puerto Rico (1) · Spain (1)